Drugs / NVGH Vi-CRM197
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01438996 | Oct → Dec 2011 | typhoid fever | Novartis | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NVGH Vi-CRM197 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01438996 ↗ |
| Modality | Vaccine | “Vi-CRM197 glycoconjugated vaccine” NCT01438996 ↗ |